ADIL Q1 2026 Earnings Surprise EPS Beat Amid PreRevenue Phase Stock Drops 957 NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds Northwest Bancshares Q1 2026 Earnings EPS Surges Past Consensus as Expense Discipline Supports Results Concentrix CNXC Q1 2026 Earnings EPS Miss and Revenue NonDisclosure Weigh on Sentiment Arcturus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Pipeline Progress Continues OptimizeRx OPRX Q1 2026 Earnings Massive EPS Beat Sends Stock Higher